Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
56.3%
% of CANC's 48 holdings also in CNCR
42.2%
% of CNCR's 64 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
SUMMIT THERAPEUTICS INC | 3.9% | 2.2% | 2.2% |
|
EXELIXIS INC | 3.8% | 1.8% | 1.8% |
 |
GENMAB A/S SPONSORED ADR | 3.4% | 1.7% | 1.7% |
|
JANUX THERAPEUTICS, INC. | 2.2% | 1.7% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 5.7% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to CNCR
|
ELI LILLY & CO | 5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.1% |
|
BRIDGEBIO PHARMA, INC. | 4.5% |
|
NOVARTIS AG | 4.3% |
 |
ASTRAZENECA PLC | 4.2% |
|
REVOLUTION MEDICINES, INC. | 4.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.0% |
 |
DAIICHI SANKYO CO LTD | 2.9% |
|
AMGEN INC | 2.8% |
|
BEIGENE LTD. SPONSORED ADR | 2.7% |
CANC Underweight Relative to CNCR
|
FATE THERAPEUTICS INC | -2.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -1.8% |
|
2SEVENTY BIO, INC. | -1.8% |
|
Y-MABS THERAPEUTICS, INC. | -1.8% |
 |
BIONTECH SE SPONSORED ADR | -1.8% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
HUTCHISON CHINA MEDITECH LIMITED SPO | -1.6% |
|
ITEOS THERAPEUTICS, INC. | -1.6% |
|
IMMATICS N.V. | -1.5% |
|
IMMUNITYBIO INC | -1.5% |